Description
Small Molecule Therapeutics for Schizophrenia, 2015
Topics in Medicinal Chemistry Series, Vol. 13
Coordinators: Celanire Sylvain, Poli Sonia
Language: EnglishSubjects for Small Molecule Therapeutics for Schizophrenia:
Publication date: 08-2016
Support: Print on demand
Publication date: 10-2014
323 p. · 15.5x23.5 cm · Hardback
Description
/li>Contents
/li>Comment
/li>
Antipsychotics and the Dopamine–Serotonin Connection.- GLYT1 Inhibitors: From Hits to Clinical Candidates.- Metabotropic Glutamate Receptor 2 Activators.- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders.- Muscarinic Acetylcholine Receptor Activators.- Nicotinic Acetylcholine Receptor Modulators.-The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
These books may interest you
Carbohydrates as Drugs 210.99 €
Alzheimer's Disease II 210.99 €
The Blood Brain Barrier (BBB) 158.24 €